{"transactions":[{"id":737582,"issuer":{"id":6917,"kind":"organization","name":"Cardiff Oncology, Inc."},"owners":[{"id":38092,"kind":"person","name":"White Lale","position":1,"cik":"0001635493","reported_name":"White Lale","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options","published_at":"2026-06-16T01:30:06.000Z","date":"2026-06-11","kind":"grant","planned":false,"acquired":true,"shares":40565,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":199246,"derivative":{"exercise_price":1.59,"exercise_date":"2027-06-11","expiration_date":"2036-06-11","underlying":"Common Stock","underlying_shares":40565},"source":{"system":"sec-edgar","filing":"0001635493-26-000002","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1213037/000163549326000002/ownership.xml","form_type":"4"}},{"id":1100038,"issuer":{"id":6917,"kind":"organization","name":"Cardiff Oncology, Inc."},"owners":[{"id":38092,"kind":"person","name":"White Lale","position":1,"cik":"0001635493","reported_name":"White Lale","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options","published_at":"2025-06-27T23:40:25.000Z","date":"2025-06-26","kind":"grant","planned":false,"acquired":true,"shares":40565,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":158681,"derivative":{"exercise_price":3.16,"exercise_date":"2026-06-26","expiration_date":"2035-06-26","underlying":"Common Stock","underlying_shares":40565},"source":{"system":"sec-edgar","filing":"0001641172-25-016989","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1213037/000164117225016989/ownership.xml","form_type":"4"}},{"id":1465598,"issuer":{"id":6917,"kind":"organization","name":"Cardiff Oncology, Inc."},"owners":[{"id":38092,"kind":"person","name":"White Lale","position":1,"cik":"0001635493","reported_name":"White Lale","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options","published_at":"2024-07-01T20:09:32.000Z","date":"2024-06-27","kind":"grant","planned":false,"acquired":true,"shares":29700,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":146974,"derivative":{"exercise_price":2.33,"exercise_date":"2025-06-27","expiration_date":"2034-06-27","underlying":"Common Stock","underlying_shares":29700},"source":{"system":"sec-edgar","filing":"0001628280-24-030643","document":"wk-form4_1719864565.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1213037/000162828024030643/wk-form4_1719864565.xml","form_type":"4"}},{"id":1849147,"issuer":{"id":6917,"kind":"organization","name":"Cardiff Oncology, Inc."},"owners":[{"id":38092,"kind":"person","name":"White Lale","position":1,"cik":"0001635493","reported_name":"White Lale","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options","published_at":"2023-06-20T21:05:53.000Z","date":"2023-06-15","kind":"grant","planned":false,"acquired":true,"shares":27700,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":117274,"derivative":{"exercise_price":1.59,"exercise_date":"2024-06-15","expiration_date":"2033-06-15","underlying":"Common Stock","underlying_shares":27700},"source":{"system":"sec-edgar","filing":"0001628280-23-022736","document":"wk-form4_1687295135.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1213037/000162828023022736/wk-form4_1687295135.xml","form_type":"4"}},{"id":2153943,"issuer":{"id":6917,"kind":"organization","name":"Cardiff Oncology, Inc."},"owners":[{"id":38092,"kind":"person","name":"White Lale","position":1,"cik":"0001635493","reported_name":"White Lale","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-09-20T22:08:57.000Z","date":"2022-09-19","kind":"purchase","acquired":true,"shares":15000,"price":1.635,"value":24525.0,"ownership":{"direct":false,"nature":"Trust"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $1.625 to $1.64. Full information regarding the number of shares purcahsed at each separate price can be furnished to the SEC staff upon request."}],"balance_after":113788,"source":{"system":"sec-edgar","filing":"0001628280-22-025265","document":"wf-form4_166371172268717.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1213037/000162828022025265/wf-form4_166371172268717.xml","form_type":"4"}},{"id":2211550,"issuer":{"id":6917,"kind":"organization","name":"Cardiff Oncology, Inc."},"owners":[{"id":38092,"kind":"person","name":"White Lale","position":1,"cik":"0001635493","reported_name":"White Lale","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options","published_at":"2022-07-06T20:10:40.000Z","date":"2022-07-05","kind":"exercise","acquired":false,"shares":28858,"price":2.6,"value":75030.8,"ownership":{"direct":true},"balance_after":60716,"derivative":{"exercise_price":2.6,"exercise_date":"2021-06-17","expiration_date":"2030-06-17","underlying":"Common Stock","underlying_shares":28858},"source":{"system":"sec-edgar","filing":"0001628280-22-018607","document":"wf-form4_165713821643094.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1213037/000162828022018607/wf-form4_165713821643094.xml","form_type":"4"}},{"id":2211549,"issuer":{"id":6917,"kind":"organization","name":"Cardiff Oncology, Inc."},"owners":[{"id":38092,"kind":"person","name":"White Lale","position":1,"cik":"0001635493","reported_name":"White Lale","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-07-06T20:10:40.000Z","date":"2022-07-05","kind":"exercise","acquired":true,"shares":28858,"price":2.6,"value":75030.8,"ownership":{"direct":false,"nature":"Trust"},"balance_after":98788,"source":{"system":"sec-edgar","filing":"0001628280-22-018607","document":"wf-form4_165713821643094.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1213037/000162828022018607/wf-form4_165713821643094.xml","form_type":"4"}},{"id":2339542,"issuer":{"id":6917,"kind":"organization","name":"Cardiff Oncology, Inc."},"owners":[{"id":38092,"kind":"person","name":"White Lale","position":1,"cik":"0001635493","reported_name":"White Lale","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options","published_at":"2022-03-10T23:43:34.000Z","date":"2022-03-09","kind":"grant","acquired":true,"shares":26800,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":89574,"derivative":{"exercise_price":2.5,"exercise_date":"2023-03-09","expiration_date":"2032-03-09","underlying":"Common Stock","underlying_shares":26800},"source":{"system":"sec-edgar","filing":"0001628280-22-005797","document":"wf-form4_164695579568634.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1213037/000162828022005797/wf-form4_164695579568634.xml","form_type":"4"}},{"id":2669861,"issuer":{"id":6917,"kind":"organization","name":"Cardiff Oncology, Inc."},"owners":[{"id":38092,"kind":"person","name":"White Lale","position":1,"cik":"0001635493","reported_name":"White Lale","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options","published_at":"2021-06-14T20:14:14.000Z","date":"2021-06-10","kind":"grant","acquired":true,"shares":22000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":62774,"derivative":{"exercise_price":7.98,"exercise_date":"2022-06-10","expiration_date":"2031-06-10","underlying":"Common Stock","underlying_shares":22000},"source":{"system":"sec-edgar","filing":"0001628280-21-012178","document":"wf-form4_162370162899357.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1213037/000162828021012178/wf-form4_162370162899357.xml","form_type":"4"}},{"id":3104082,"issuer":{"id":6917,"kind":"organization","name":"Cardiff Oncology, Inc."},"owners":[{"id":38092,"kind":"person","name":"White Lale","position":1,"cik":"0001635493","reported_name":"White Lale","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options","published_at":"2020-06-19T20:16:52.000Z","date":"2020-06-17","kind":"grant","acquired":true,"shares":28858,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":40774,"derivative":{"exercise_price":2.6,"exercise_date":"2021-06-17","expiration_date":"2030-06-17","underlying":"Common Stock","underlying_shares":28858},"source":{"system":"sec-edgar","filing":"0001104659-20-075240","document":"a4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1213037/000110465920075240/a4.xml","form_type":"4"}},{"id":3145141,"issuer":{"id":6917,"kind":"organization","name":"Cardiff Oncology, Inc."},"owners":[{"id":38092,"kind":"person","name":"White Lale","position":1,"cik":"0001635493","reported_name":"White Lale","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-05-18T20:16:11.000Z","date":"2020-05-14","kind":"purchase","acquired":true,"shares":69930,"price":1.43,"value":99999.9,"ownership":{"direct":false,"nature":"Trust"},"balance_after":69930,"source":{"system":"sec-edgar","filing":"0001104659-20-063176","document":"a4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1213037/000110465920063176/a4.xml","form_type":"4"}},{"id":3165238,"issuer":{"id":6917,"kind":"organization","name":"Cardiff Oncology, Inc."},"owners":[{"id":38092,"kind":"person","name":"White Lale","position":1,"cik":"0001635493","reported_name":"White Lale","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options","published_at":"2020-05-01T20:16:37.000Z","date":"2020-04-16","kind":"grant","acquired":true,"shares":11916,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"3,972 of the Stock Options vest on each of 4/16/2021, 2022 and 2023"}],"balance_after":11916,"derivative":{"exercise_price":0.98,"expiration_date":"2030-04-16","underlying":"Common Stock","underlying_shares":11916},"source":{"system":"sec-edgar","filing":"0001104659-20-055489","document":"a4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1213037/000110465920055489/a4.xml","form_type":"4"}},{"id":4159936,"issuer":{"id":171845,"kind":"organization","name":"CombiMatrix Corp","symbol":"CBMX"},"owners":[{"id":38092,"kind":"person","name":"White Lale","position":1,"cik":"0001635493","reported_name":"White Lale","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-11-16T17:55:16.000Z","date":"2017-11-14","kind":"other","acquired":false,"shares":7792,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Disposed of pursuant to merger agreement between issuer and Invitae Corporation in exchange for 6,772 shares of Invitae common stock having a market value of $7.86 per share on the effective date of the merger."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001179110-17-014228","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1383183/000117911017014228/edgar.xml","form_type":"4"}},{"id":4159935,"issuer":{"id":171845,"kind":"organization","name":"CombiMatrix Corp","symbol":"CBMX"},"owners":[{"id":38092,"kind":"person","name":"White Lale","position":1,"cik":"0001635493","reported_name":"White Lale","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-11-16T17:55:16.000Z","date":"2017-11-14","kind":"disposition_to_issuer","acquired":false,"shares":835,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents common stock of the issuer underlying restricted stock units that were cancelled in the merger pursuant to merger agreement between issuer and Invitae Corporation in exchange for 725 shares of Invitae common stock having a market value of $7.86 per share on the effective date of the merger."}],"balance_after":7792,"source":{"system":"sec-edgar","filing":"0001179110-17-014228","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1383183/000117911017014228/edgar.xml","form_type":"4"}}]}